DexCom (DXCM)
(Delayed Data from NSDQ)
$114.54 USD
+1.03 (0.91%)
Updated Jun 27, 2024 04:00 PM ET
3-Hold of 5 3
D Value A Growth B Momentum B VGM
Brokerage Reports
DexCom, Inc. [DXCM]
Reports for Purchase
Showing records 401 - 413 ( 413 total )
Company: DexCom, Inc.
Industry: Medical - Products
Company: DexCom, Inc.
Industry: Medical - Products
THE NEXT PERFECT STORM-OBAMACARE WILL STRETCH THE SYSTEM TO ITS ULTIMATE LIMIT
Provider: CAPSTONE INVESTMENTS
Analyst: PUTNAM J
Company: DexCom, Inc.
Industry: Medical - Products
Company: DexCom, Inc.
Industry: Medical - Products
Company: DexCom, Inc.
Industry: Medical - Products
Q2 Financials Meet Expectations. SEVEN PLUS Demand Remains Strong and New Product Launches Anticipated.
Provider: WEDBUSH SECURITIES INC.
Analyst: LAU R
Company: DexCom, Inc.
Industry: Medical - Products
Company: DexCom, Inc.
Industry: Medical - Products
Q2 Preview: We are at the Mid-Range of Consensus and Believe Our Estimates are Achievable.
Provider: WEDBUSH SECURITIES INC.
Analyst: LAU R
Company: DexCom, Inc.
Industry: Medical - Products
70TH ANNUALAMERICAN DIABETES ASSOCIATION MEETING CONFIRMS THESIS - BUY
Provider: CAPSTONE INVESTMENTS
Analyst: PUTNAM J
Company: DexCom, Inc.
Industry: Medical - Products
Life Sciences: Biopharmaceuticals / Biotechnology.
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L